{"name":"Masimo Corporation","slug":"masimo","ticker":"MASI","exchange":"NASDAQ","domain":"masimo.com","description":"Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings. Masimo has also operated in the consumer audio and wearable device markets. In 2026, Danaher Corporation agreed to acquire the company for $10 billion.","hq":"Irvine, CA","founded":0,"employees":"2200","ceo":"Joe Kiani","sector":"Medical Devices / Patient Monitoring","stockPrice":178.4,"stockChange":-0.01,"stockChangePercent":-0.01,"marketCap":"$9.3B","metrics":{"revenue":1558499968,"revenueGrowth":8.5,"grossMargin":61.6,"rdSpend":126400000,"netIncome":-151500000,"cash":152300000,"dividendYield":0,"peRatio":44.3,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-01","type":"earnings","headline":"Masimo Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Masimo Corporation reported its fourth quarter and full year 2023 financial results, with revenue of $1.04 billion and net income of $243 million.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"deal","headline":"Masimo Acquires Sound United","summary":"Masimo Corporation acquired Sound United, a leading manufacturer of home audio and video products.","drugName":"","sentiment":"neutral"},{"date":"2023-05-01","type":"regulatory","headline":"Masimo Receives FDA Clearance for Radical-7 Pulse Oximeter","summary":"Masimo Corporation received FDA clearance for its Radical-7 pulse oximeter, a non-invasive patient monitoring device.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxPWFpoYW1fa3BkN3JNaFJXTnVaOFVSQld0cENscUh5LVJGeUIzSjY0MGFSYjNlbU1GVDU5TGNvMS1mTkxLN3FPaGloS0Ffbm9GRk1JbHNzNEpJWFZwQU9Va1BFZUNKcXBKVXdQT0VVYlVhc3IyR1k4SzlENnlKd2tYUlZGTnlscjlxaWN3MkZTakd4NThSQ3g4cXhzbW42bzYybV94Q3ZRNDk1V3hTcFZQOGJ2WmdZYWlKSGNnMjdybmZFWkJOS3FhSE1vOTBEUnUzYXhUZVBucTMtRW1yeWVRWElISnotNTdnWEJwMlZlUnBmZ0hTLWdzcVFLUld4andrVS1vX29VUXpGZkFDd3pOUC1NN2V4THh6RkxUWHBYbFpaeDZZaVdBeVB6VVVvRXBPZF9pVFZjVmdqSVk?oc=5","date":"2026-04-01","type":"pipeline","source":"Business Wire","summary":"Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA - Business Wire","headline":"Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed S","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPOXBieUw5Nkc1R01FSEZFYVdpeXI1cFNhTFJSVURwLTZPb2ZCZXU2RldSaU1SSmVKV25Ob2NxNDJKV09qV3gxMF9HNlhBQU9xd1ZxMlltcks2Y05iNTE1YTFNZnQ1MjYydVAyVm9ONExzYmlvN2dFUnNwd0ljb0F1V3hNQlFZYW9acWhHNGY1bEx4aUxuVkJEdzBtS1JCYXpYRUIwbVlEUzczM2Jrc2wtaFFqNUhMSVdFM0xaZG05U2MxdVdUX09Od1NYYjFlWmdYOTVoRUxRaXNRenFONXJYVFdiTWs?oc=5","date":"2026-03-11","type":"pipeline","source":"MarketBeat","summary":"Schroder Investment Management Group Has $48.12 Million Holdings in Masimo Corporation $MASI - MarketBeat","headline":"Schroder Investment Management Group Has $48.12 Million Holdings in Masimo Corporation $MASI","sentiment":"neutral"},{"date":"2026-02-27","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOSzlPdlYtVTZKaVdCSlM2MERaY0lfVDN3U1paR0FqZzFXVnM3dWxtcjZKV1lJSmctQmpzWDN0Sm1ZY2wtNnRvZ2xjQ1JuU3k4VWtvTjE4Wk9uZXNBanVucmphRm9nQlluS1FXQzBrZFJPWU1LenVUQ0p6VVpUOXlsRmd0OTNoSlRna3o5QTdpelJMek1IQVRwbG1tcE1MdFlFeTZLTGlnUGtreEM3Q2NqbzJQRk42Tm1uNi1teHJWclNjZw?oc=5","date":"2026-02-18","type":"pipeline","source":"TIKR.com","summary":"Masimo Stock Is Up 34% Last Week. Here’s How Danaher’s Nearly $10 Billion Acquisition Changes the Story - TIKR.com","headline":"Masimo Stock Is Up 34% Last Week. Here’s How Danaher’s Nearly $10 Billion Acquisition Changes the Story","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxQUGJNaGhkYU5VTnZFeHRGOGg3a2p0TGNMdHFPb0E1dDZkcm11RExIZ2pYRW4tdy1aM3dhZjdhRndKV1RoUjk4RkhKa212b2hRREgyVThtMW5rRllXakg0U3Mtckt2LVhfNmhzRFpTV2drWWMwdkcxTHkxRThVV2JsNUNLZGhVNWNGeHg3b3dIWEJhelVqYmNOV1J3cy1tdlUwUnEwTzhMU0NGZmcxV0ZUNV9MWlFSMUhEeFhvR1ZQTGdrbGJDM1RGbm0yYjdray1rOGpDbDY4dXhJQ1hTT1VwZC1vaS1kWVEyUVg2SDJmcUU2anFtRHp0cEx4VzJqbUFaRHMyUnNUdzJDWThGb1dNUU9JdVE2Zw?oc=5","date":"2026-02-18","type":"pipeline","source":"Business Wire","summary":"Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI - Business Wire","headline":"Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corp","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQS1dTbjZWTVZQUG9IOVhuM0NRRTB3a3M3ZTlzYUZ1WDNJV29YSmxnYnpybHpGdERTNkFOOXRHcjItQjM5blZ5MnpmTHpYVFpHMVpKc2FVU1Q3al9lcWlrWlFlWTdvcDB3V2RrWVdQSzhrTTBPOGd5VnI5VlJGN21XODRHV28?oc=5","date":"2026-02-17","type":"deal","source":"Financial Times","summary":"Danaher strikes $10bn deal for medical device maker Masimo - Financial Times","headline":"Danaher strikes $10bn deal for medical device maker Masimo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPOFVoRlgtY3NEcDB0X203M1JpR1A3NmE1TnEwbUtlbmxQOGFPb1hfOWRleVgxSkkzeHF0U1NkdG9tczdyWEV3LURsVFdXSUxPeU1ESmdGeHBKV3dZWEhvXzVPMGNEQjVaR2lEaFpZc29GVWNHM2Y2Rkg4NnNYTGIzRF9hUzVPZUIwXzUzVUdXZjVqUzdCWkZBOXZtUnNWbmFXZ1lr?oc=5","date":"2026-02-17","type":"deal","source":"Reuters","summary":"Danaher to buy Masimo in $9.9 billion deal in diagnostics push - Reuters","headline":"Danaher to buy Masimo in $9.9 billion deal in diagnostics push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNSDZ6UFRfQ3BHQUtyVng2akNtT0tzMXVRem83b1J5NEJpdEZTUmlvd1ZWcmI2Rjg2SHFXbW9NVE5zQVdyblJlcFJWNlBhb21UZFR2bHMwby01aFVQVmJEVW1xQ3dHbmFBR2VTV0EwbTEyLVJFNUliMHpEYUlYbFRibzhKQ1JwY1FRRE1aLUwySzZGU3huYWx2Y1E3RXMwUndFZ09nSFdPTGxUTzlrcERBQ210RQ?oc=5","date":"2026-02-17","type":"pipeline","source":"Seeking Alpha","summary":"Masimo: Danaher Acquisition Saves The Company From Lackluster Performance (NASDAQ:MASI) - Seeking Alpha","headline":"Masimo: Danaher Acquisition Saves The Company From Lackluster Performance (NASDAQ:MASI)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQeXFROUk2cUZfUE53MXJNZTl0QmFLbnY2MnNYUjBZWjNHWkN4WG5vZnZzc0dFV1d1eFBGaTZuSUc0VEZFRmM1ZjFqNWZpNlROdTFmMTRpRG03dGcwRzBPeENCbnVUOEVrMTBpUS1INU1nM0VwT2txbFFabkViOWw1QWlXclllOEhlUHVRZjJ2cWd3ZnhsTFdxTk00cU9vNFplR01RZlNtRFRRLXE3YUJiQVYxV184UlNpLUE?oc=5","date":"2026-02-17","type":"deal","source":"proactiveinvestors.com","summary":"Danaher to acquire Masimo in $9.9B all-cash deal - proactiveinvestors.com","headline":"Danaher to acquire Masimo in $9.9B all-cash deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPTHRKY2E0eHJSUVlCQ1ZEMHRHVm53WXIzUUI5T2hsMEw4RVowblRqb040VlFfenZtRFdKYUp4S2xpRjJFVGNZVGE5b3VzUVR3WDJWX3JMZHZya0J3amc3Y2RSbGc4NHVvcXBaSXY4YW9oVDd5WW0yV21WQXZNZmlkeUFjLWFSQ0g2MUxfYnhETzRweklKUF9COGRXM1BlajRuVkFZaTNZM0s0bUVyc1YtbmpOYWhVQWZHZlNXSURiWWhqVGNZVjZ6YnFuaU9NTXd4QzhKOU94SUFOTHJKNnJZRHZ4UGVoNVVqVWxEclYxSlI?oc=5","date":"2026-02-17","type":"pipeline","source":"PR Newswire","summary":"SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Masimo Corporation (NASDAQ: MASI) - PR Newswire","headline":"SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Masimo Corporation (NASDAQ: MASI)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNeDFDRVFPM2dBUmxIdFBjNGt5aVU2OVlKQzItbjMweEZ4TGVqRGE0bXhYV1AwQTFtcFRLamhPVUM3N2lrVVRJcFJwQjBueXBxRDNBV2xCOGFaWUpfQmFYVWNGR3NkeF9EN1FNVER5dXpVZzFEYmM1VmJHelo3djBOaFhwX05MZk80V3dybWtGZm9DOGFvLTlCQzNoOHhpdVpEVktrZkVES2YwWjFRSkNBTnotc3EzQklIOWlIYkZ2eTVnMXpzclE?oc=5","date":"2026-02-17","type":"deal","source":"Reuters","summary":"Danaher closes in on nearly $10 billion deal for Masimo, FT reports - Reuters","headline":"Danaher closes in on nearly $10 billion deal for Masimo, FT reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQcXlpc1h3XzFfTTkxWU13aUljc3VFVGFZRXk3WXg5YkxLMHJKM3NBTkxOM3hTeTBESU82N1lBY3pPYU1TR0xxcHM3eXNiYVgxNjlxaE5UaFFrSndSeU41Q2tkSmpheVFGMXh1cU9DSHptZE1hV2M0VFFqbmlHU1RMNUEtU1IzY0JpT1BvQnhkMjRzMWhlUU1BM05qbnhvQ2ZTbGZtb1dYcVV1d1E5MkRfYk83dzJldWpJMm5yWg?oc=5","date":"2026-02-12","type":"earnings","source":"TradingView","summary":"WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up - TradingView","headline":"WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFB6Z2ZDNkt0c2s3REMzRGxvZHdpdjN3TkhHSXlWcTNWUzdjZG8zcTNEM3ktRE5aZWVqaTQ3OU9ISzdhWk9sWXBuaVpfWXNBa1NFXzJJUE9KMDU5ZWhzLWQtdmJwXzY4Z2FPUWQtTk56eUhuOXpUdDV6ZGhR?oc=5","date":"2025-11-05","type":"earnings","source":"Yahoo Finance","summary":"MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand - Yahoo Finance","headline":"MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Philips Healthcare","Medtronic","GE Healthcare"],"therapeuticFocus":["Patient Monitoring","Anesthesia Monitoring"],"financials":{"source":"sec_edgar+yahoo","revenue":1239153000,"revenuePeriod":"2022-01-01","revenueHistory":[{"value":1239153000,"period":"2022-01-01"},{"value":307414000,"period":"2021-10-02"},{"value":305118000,"period":"2021-07-03"},{"value":299043000,"period":"2021-04-03"},{"value":1143744000,"period":"2021-01-02"},{"value":278112000,"period":"2020-09-26"}],"grossProfit":945200000,"grossProfitHistory":[{"period":"2025-12-31","value":945200000},{"period":"2024-12-31","value":794300000},{"period":"2023-12-31","value":765600000},{"period":"2022-12-31","value":1058800000}],"rdSpend":126400000,"rdSpendHistory":[{"period":"2025-12-31","value":126400000},{"period":"2024-12-31","value":182200000},{"period":"2023-12-31","value":130500000},{"period":"2022-12-31","value":191400000}],"sgaSpend":506000000,"operatingIncome":312800000,"operatingIncomeHistory":[{"period":"2025-12-31","value":312800000},{"period":"2024-12-31","value":63500000},{"period":"2023-12-31","value":183800000},{"period":"2022-12-31","value":210000000}],"netIncome":-151500000,"netIncomeHistory":[{"period":"2025-12-31","value":-151500000},{"period":"2024-12-31","value":-304900000},{"period":"2023-12-31","value":81500000},{"period":"2022-12-31","value":143500000}],"eps":-2.83,"epsHistory":[{"period":"2025-12-31","value":-2.83},{"period":"2024-12-31","value":-5.72},{"period":"2023-12-31","value":1.51},{"period":"2022-12-31","value":2.6}],"cash":152300000,"cashHistory":[{"period":"2025-12-31","value":152300000},{"period":"2024-12-31","value":123600000},{"period":"2023-12-31","value":163000000},{"period":"2022-12-31","value":202900000}],"totalAssets":1698900000,"totalLiabilities":977700000,"totalDebt":559300000,"equity":721200000,"operatingCashflow":217800000,"operatingCashflowHistory":[{"period":"2025-12-31","value":217800000},{"period":"2024-12-31","value":196400000},{"period":"2023-12-31","value":94100000},{"period":"2022-12-31","value":29400000}],"capex":-24700000,"capexHistory":[{"period":"2025-12-31","value":-24700000},{"period":"2024-12-31","value":-38300000},{"period":"2023-12-31","value":-61800000},{"period":"2022-12-31","value":-56300000}],"freeCashflow":193100000,"dividendsPaid":null,"buybacks":-363700000,"employees":2200,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":143400000,"ebit":77400000,"ebitda":85500000,"period":"2026-03-31","revenue":403600000,"epsBasic":1.1,"netIncome":57100000,"rdExpense":30000000,"epsDiluted":1.09,"grossProfit":250800000,"operatingIncome":77400000},{"sga":131300000,"ebit":81500000,"ebitda":95100000,"period":"2025-12-31","revenue":412500000,"epsBasic":null,"netIncome":68300000,"rdExpense":32100000,"epsDiluted":null,"grossProfit":247300000,"operatingIncome":83900000},{"sga":116400000,"ebit":83700000,"ebitda":91900000,"period":"2025-09-30","revenue":371500000,"epsBasic":-1.86,"netIncome":-100400000,"rdExpense":30500000,"epsDiluted":-1.86,"grossProfit":230600000,"operatingIncome":83700000},{"sga":138900000,"ebit":63600000,"ebitda":72000000,"period":"2025-06-30","revenue":370900000,"epsBasic":0.95,"netIncome":51300000,"rdExpense":29900000,"epsDiluted":0.94,"grossProfit":233300000,"operatingIncome":64500000},{"sga":119400000,"ebit":77200000,"ebitda":85800000,"period":"2025-03-31","revenue":372000000,"epsBasic":-3.17,"netIncome":-170700000,"rdExpense":33900000,"epsDiluted":-3.17,"grossProfit":234000000,"operatingIncome":80700000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":-6.52,"netIncome":null,"rdExpense":null,"epsDiluted":-6.52,"grossProfit":null,"operatingIncome":null},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":178.4,"previousClose":178.41,"fiftyTwoWeekHigh":179,"fiftyTwoWeekLow":125.94,"fiftyTwoWeekRange":"125.94 - 179.0","fiftyDayAverage":177.72,"twoHundredDayAverage":153.46,"beta":1.13,"enterpriseValue":9703883776,"forwardPE":27,"priceToBook":11.84,"priceToSales":5.99,"enterpriseToRevenue":6.23,"enterpriseToEbitda":26.39,"pegRatio":0,"ebitda":367700000,"ebitdaMargin":23.6,"freeCashflow":327924992,"operatingCashflow":232000000,"totalDebt":485900000,"debtToEquity":61.6,"currentRatio":2.67,"returnOnAssets":10.2,"returnOnEquity":25,"analystRating":"3.0 - Hold","recommendationKey":"hold","numberOfAnalysts":4,"targetMeanPrice":180,"targetHighPrice":180,"targetLowPrice":180,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":1353628800,"insiderHeldPercent":5,"institutionHeldPercent":103,"sharesOutstanding":52369086,"floatShares":47632463,"sharesShort":3884472,"shortRatio":5.22,"shortPercentOfFloat":7.4,"epsTrailing":4.03,"epsForward":6.6,"revenuePerShare":29.32,"bookValue":15.06,"officers":[{"age":58,"name":"Ms. Catherine M. Szyman","title":"CEO & Director"},{"age":59,"name":"Mr. Anand  Sampath","title":"Executive Vice President of Operations"},{"age":66,"name":"Mr. Charles  Dadswell","title":"Executive VP & General Counsel"},{"age":61,"name":"Mr. Greg  Meehan","title":"Chief Commercial Officer"},{"age":50,"name":"Mr. Paul  Hataishi","title":"Senior VP & Chief Accounting Officer"},{"age":60,"name":"Mr. Yongsam  Lee","title":"Executive VP & Chief Information Officer"},{"age":80,"name":"Dr. Steven J. Barker","title":"Chairman of Scientific Advisory Board & Chief Science Officer"},{"age":null,"name":"Mr. Matthew  Brinckman","title":"Senior Vice President of FP&A and Investor Relations"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.masimo.com","phone":"949 297 7000"}}